Gilenya : Précautions et recommandation d’utilisation lors de l’initiation du traitement

Mis à jour par Phel · à 07:32 · Version 1.1875

Document Adobe Acrobat PDF (284.24 Ko)

Document ENNOV Neurologie

eNrFmG1v2jAQx9/zKaK8bxIKjHYKVCtrV6RWZW3Rpr1BJjnAmWunfgC6Tz+HUDWdnD6Yunvp2Pzv7Dv/7nB8tL4l3hK4wIz2/GYQ+R7QhKWYznv++OZ078A/6jfiDC1RddlBEE32o33fSwgSoucX88EUEBXBz4vzr6AVgPv9hhezaQaJfLJOSUyCMyQWFygv1njxkuHUuwW5YGnPz5XcfPViIbn2o79i/LfIUQJxuP1Snc0m7er3OCzEXqGqBPBzROdG0Rm30kwU50DlAEmYM35vlM4XQCbNVrvbjKxsYHEFgimewAjJxYizJU4hNe8CEQFWRmar9Br4koAsjBjFwyy5FVbiKEPrK7gbmp3+omcHci33or1mt9k57O53W51W1LQyxStHZc4evYmwDMlht9MJK+OoddCujlvtT4edENOZzmfMCJtjsAzgiHGJiKPQYTF4moWO7HC4ezFFUixygu6DTOS2R4U40tPANSvcbaTYwQ3X9CL6zP7Rp4qQ8I1ej7dsceRxga4BU1TWIGZwZnsQA0YlrOsjakdFud7mIgbxfrJ/GDVXhJGaEpzYck+TSYGQ46thPfY+nBjHSMCYu0PGD0xTthLvj6Jq6B15n29oahRlUz7pRFHL+pb90jlWU6dOFGc5hMfACaa7gGdIZ2xX5Oi8NUs9ZO3HJuymt2IJIlDTXU0sEaUz9aEZdHYX3N2zcsIo+u3kxjaHvivg99eboVEap73H6NsB3EVV0Clb6/nbL0AJgWcb72xit3vFzXBZSJmLz2G4Wq2C4oCDZPF/ikOlaLv7O+CkMyg7pRKyjlyflpXz1RG0vYUvtQ27tsLb329bbqMNyRXsEIYS2M6wOjx5f1I/9sHO3B49AYs7M5ueFWkSUFdtkpo+8x5hXRt0YOkp13C4nM1wzRNNbWLGYfk81G/EYfE01G/8Ba91GAA=